Trial Profile
Open-label, single center, non-comparative, safety study of miglustat in Japanese patients with Niemann-Pick type C disease.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III/IV
Latest Information Update: 04 Apr 2014
Price :
$35
*
At a glance
- Drugs Miglustat (Primary)
- Indications Niemann-Pick disease type C
- Focus Adverse reactions
- 04 Apr 2014 New trial record